The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis

Published:2016-03 Issue:13 Volume:34 Page:1540-1550
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Kraicer-Melamed Hannah,O’Donnell Shauna,Quach Caroline^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference56 articles.

1. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition;Global Burden of Disease Collaborators;Lancet,2015

2. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults;Bonten;N Engl J Med,2015

3. Evidence-based recommendations for immunization – methods of the National Advisory Committee on Immunization. An Advisory Committee Statement (ACS);Can Commun Dis Rep,2009

4. Current methods of the US Preventive Services Task Force: a review of the process;Harris;Am J Prevent Med,2001

5. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine;Broome;N Engl J Med,1980

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the decision-making process underlying the initial off-label use of vaccines: A scoping review;Vaccine;2024-10

2. Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Preventing Community-Acquired Pneumonia in Adults: A Population-Based Cohort Study;Vaccines;2024-09-06

3. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021;The Lancet Infectious Diseases;2024-09

4. Pneumococcal Vaccination Strategies in 50-Year-Olds to Decrease Racial Disparities: A US Societal Perspective Cost-Effectiveness Analysis;Value in Health;2024-06

5. Pneumococcal vaccination and primary care presentations for acute respiratory tract infection and antibiotic prescribing in older adults;PLOS ONE;2024-04-18